刘倩倩,博士,校聘教授,博士生导师
维多利亚老品牌vic3308“东南学者”,东南博士后合作导师。南京大学药学博士。现任中国药理学会抗炎免疫药理专业委员会青年委员,并担任 Acta Pharmaceutica Sinica B 杂志的同行评审人。主持两项博士后研究项目。目前以一作/共一/共同通讯作者身份在Nature Aging、Arthritis & Rheumatology、Nature Communications、Acta Pharmaceutica Sinica B、Phytomedicine等期刊发表SCI论文共7篇。
研究方向:老年病药理学,主要致力于骨关节炎软骨退行性病变的机制研究及其药物干预。
邮箱:liuqianqian_0320@ahmu.edu.cn
主持课题:
1.维多利亚老品牌vic3308人才启动项目,0601142201,主持。
2.中国博士后科学基金第74批面上资助,2023M741642,主持。
3.中国博士后科学基金第17批特别资助,2024T170399,主持。
部分发表文章:(10篇以内)
第一作者和通讯作者SCI论文:
1.Qianqian Liu#, Mingrui Han#, Zhigui Wu#, Wenqiang Fu#, Jun Ji, Qingqing Liang, Minjia Tan, Linhui Zha, jian Gao, Dongquan shi, Qing jiang, Ziying Sun, Yuping Lai, Qiang Xu*, Yang Sun*. DDX5 inhibits hyaline cartilage fibrosis and degradation in osteoarthritis via alternative splicing and G-quadruplex unwinding.Nature Aging, 2024 May;4(5):664-680 (Q1, IF:16.6, #Co-first author, *Co-corresponding author).
2.Qianqian Liu#, Linhui Zhai#, Mingrui Han#, Dongquan Shi#, Ziying Sun, Shuang Peng, Meijing Wang, Chenyang Zhang, Jian Gao, Wenjin Yan, Qing Jiang, Dijun Chen, Qiang Xu, Minjia Tan*, Yang Sun*. SH2 Domain–Containing Phosphatase 2 Inhibition Attenuates Osteoarthritis by Maintaining Homeostasis of Cartilage Metabolism via the Docking Protein 1/Uridine Phosphorylase 1/Uridine Cascade.Arthritis & Rheumatology, 2022, 74(3): 462-474 (Q1, IF: 13.3).
3.Qianqian Liu#, Jiao Qu#, Mingxia Zhao, Qiang Xu, Yang Sun*. Targeting SHP2 as a promising strategy for cancer immunotherapy.Pharmacological Research, 2020, 152: 104595 (Q1, IF: 9.3).
4.Fenli Shao#,Qianqian Liu#, Yuyu Zhu#, Zhidan Fan#, Wenjun Chen, Shijia Liu, Xiaohui Li, Wenjie Guo, Gen-Sheng Feng, Haiguo Yu*, Qiang Xu*, Yang Sun*. Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis.Nature communications, 2021, 12(1): 6540(Q1, IF: 16.6).
5.Ziying Sun#,Qianqian Liu#, Zhongyang Lv, Jiawei Li, Xingquan Xu, Heng Sun, Maochun Wang, Kuoyang Sun, Tianshu Shi, Zizheng Liu, Guihua Tan, Wenqiang Yan, Rui Wu, Yannick Xiaofan Yang, Shiro Ikegawa, Qing Jiang, Yang Sun*, Dongquan Shi*. Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling.Acta Pharmaceutica Sinica B, 2022, 12(7): 3073-3084(Q1, IF: 14.5).
6.Jiao Qu#, Qianqian Liu#, Guoquan You, Ling Ye, Yiguang Jin, Lingdong Kong, Wenjie Guo, Qiang Xu, Yang Sun*. Advances in ameliorating inflammatory diseases and cancers by andrographolide: pharmacokinetics, pharmacodynamics and perspective.Medicinal Research Reviews, 2022 May;42(3):1147-1178 (Q1, IF: 13.3).
7.Mingrui Han#,Chengxi Li#,Chenyang Zhang#,Chenglin Song,Qiang Xu,Qianqian Liu*,Jianming Guo*,Yang Sun*. Single-cell transcriptomics reveals the natural product Shi-Bi-Man promotes hair regeneration by activating the FGF pathway in dermal papilla cells. Phytomedicine, 2022 Sep:104:154260(Q1, IF: 7.9).